Central Glass Co.,Ltd.
4044・Prime Market・Chemicals
Governance
In June 2025, the company transitioned to a company with an audit and supervisory committee. The Board of Directors consists of 10 members (including 6 outside directors, with independent outside directors comprising the majority). The Nomination and Compensation Committee, established in 2019 and composed of a majority of independent outside directors, ensures transparency and fairness in the nomination and compensation processes.
Risk Management
The company has adopted a three-lines-of-defense model based on the Integrated Risk Management Regulations, under which the President and Executive Officer determines response policies following deliberation at the Risk Management Committee meeting. A framework has been established whereby specialized committees for environment and safety, compliance, information security, and other areas report risk information to the Board of Directors.
Shareholder Returns
The basic policy is to continue stable dividends, with an annual dividend floor of ¥170 per share set for the FY2025–FY2027 period under the Medium-Term Management Plan (FY2025–FY2030). The annual dividend for FY2026 (ending March 2026) is ¥170 (interim ¥85 + year-end ¥85), with total dividends of ¥4,298 million, a payout ratio of 50.4%, and DOE of 3.5%. An annual dividend of ¥170 is also planned for FY2027 (ending March 2027).
Dividend Policy
The basic policy is to pay stable dividends commensurate with business performance from a long-term perspective. During the FY2025–FY2027 period under the Medium-Term Management Plan (FY2025–FY2030), while advancing enhanced R&D and active capital investment in specialty products, the company has set an annual dividend floor of ¥170 per share in line with its basic policy of continuing stable dividends. The annual dividend for FY2026 (ending March 2026) is ¥170 (DOE: 3.5%, payout ratio: 50.4%). An annual dividend of ¥170 (interim ¥85 + year-end ¥85) is also planned for FY2027 (ending March 2027).
ESG
The company has conducted a quantitative assessment of climate change risks and opportunities in line with TCFD recommendations (transition risk of approximately ¥6.1 billion in cost increases by 2030, and an opportunity of approximately ¥87.0 billion in sales increases from decarbonization-contributing products), and has set targets of a 60% reduction in GHG emissions (Scope 1, 2) by FY2030 compared to FY2013 levels, and net zero by 2050. In terms of human capital, using "Smile" as a keyword, the company promotes DE&I, health management (having obtained Certified Health & Productivity Management Organization Recognition 2026), and has set KPIs for human resource development, positioning the provision and expansion of products that address social issues as its most important materiality.
Last updated: June 22, 2026